Otros idiomas AccuStem Sciences, Inc.

Acciones

ACUT

US00444A1016

Mercado cerrado - OTC Markets Otros sitios de cotización 20:38:28 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,388 ^USD	+40,58 %		0,00 %	-37,99 %

22/03	AccuStem Sciences, Inc. informa de los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI
2023	AccuStem Sciences, Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	17/07/23
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	17/07/23
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	11/07/23
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	09/06/23
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	09/06/23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23
AccuStem Announce Strategic Clinical and Operational Partnership	31/05/23
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	31/05/23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/05/23
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	02/05/23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/02/23
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	06/12/22
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22/11/22
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	16/11/22
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors	16/11/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas AccuStem Sciences, Inc.

Acciones

ACUT

US00444A1016

Otros idiomas

Filtros